Galantamine Hydrobromide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Galantamine Hydrobromide drug offered from Mylan Pharmaceuticals Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | galantamine hydrobromide |
SUBSTANCE NAME: | GALANTAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-01-24 |
END MARKETING DATE: | 0000-00-00 |
Galantamine Hydrobromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Galantamine Hydrobromide from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8(mg/1) |
START MARKETING DATE: | 2011-01-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-8105_ed04edf2-45c2-4fbc-a5b4-a01456d77954 |
PRODUCT NDC: | 0378-8105 |
APPLICATION NUMBER: | ANDA090900 |
Other GALANTAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: